Corindus Vascular Robotics, Inc. CVRS Cash Flow

Corindus vascular robotics, inc. (CVRS)

CashFlow / TTM

Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Operating activities
Net loss
-	-34,616	-	-	-	-34,288	-34,123	-35,943	-36,156	-35,336	-33,078	-30,516	-29,512	-29,221	-28,763	-28,082	-38,895	-31,656	-24,541	-18,044	-229	-267	-291	-265	-245	-189	-133	-113	-93	-51	0	0	0
Adjustments to reconcile net loss to net cash flows used in operating activities:
Loss on disposal of fixed assets
-	-	-	-	-	-	-	-	-	-	-81	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
920	883	853	700	686	711	723	693	706	691	725	760	763	749	706	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
4,245	3,539	3,235	2,956	2,625	2,774	2,892	2,914	2,960	2,812	2,366	1,838	1,280	753	505	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of interest expense
497	410	328	220	126	60	101	180	269	349	422	488	547	597	625	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Write down of inventories
-	-	268	215	325	259	268	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of available-for-sale securities
-	-	-	-	-	-	-	-	-	-	15	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant liability revaluation
-	-	-120	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of website development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	8	8	8	8	8	8	8	8	5	0	0	0
In-kind compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	10	10	10	10	10	10	10	10	9	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
2,997	1,852	1,736	1,302	1,378	1,613	2,479	724	311	-875	-494	-36	-397	1,048	404	89	494	187	438	441	-1	39	22	6	11	-24	-10	1	-11	-15	0	0	0
Due from related party
-	-	-	-	-	-	-250	0	0	-125	250	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
129	341	-130	572	338	260	91	8	24	44	-143	-639	-130	-181	17	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred inventory costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	102	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
-940	-830	1,026	865	1,439	1,797	1,638	1,932	1,574	1,246	216	180	365	269	346	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease right-of use asset, deposits and other assets
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposits and other assets
-	-	-	-	-	-	1	-6	-4	-4	-7	-7	-10	-10	-56	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable, accrued expenses and other liabilities
2,455	-6	689	164	1,292	1,824	1,817	1,555	1,205	295	1,530	720	322	31	-380	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer deposits
-	-	-	-	-	-1,905	93	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	-0	0	0	0	-	-	-	-
Security deposit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	-	-	-	-
Bank overdraft
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-3	-3	0	0	3	0	0	0	-	-	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	-3	-3	-4	1	1	-4	-6	1	1	0	0	0
Accrued expenses and other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	98	38	29	18	18	0	0	0
Deferred revenue
-	-	-	-	-	-	-	196	618	133	72	-212	-160	318	73	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued consulting expense-related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-
Other accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-
Net cash used in operating activities
-29,001	-30,701	-32,034	-34,485	-35,249	-34,497	-32,358	0	0	0	-	-	-	-	-	-	-	-	-	-	-82	-96	-91	-105	-82	-92	-86	-70	-66	-31	0	0	0
Investing activities
Purchase of property and equipment
652	780	736	579	536	266	245	300	431	533	531	292	223	183	268	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	0	0	-27,879	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Maturities of available-for-sale securities
-	-	-	-	-	-	-	-	-	-	20,553	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collection of notes receivable
-	-	-	-	-	-	-	-	-	-	65	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
-	-	-	-	-	-	-	-	-	-	-	0	0	-11,770	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Website development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	25	26	0	0	0
Net cash used in investing activities
-652	-780	-736	-579	-536	-195	-174	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-25	-26	0	0	0
Financing activities
Payments of financing costs from issuance of long-term debt and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of issuance costs
0	0	-	-	-	-	44,611	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Proceeds from issuance of long term debt and warrants, net of deferred financing costs and discounts
2,732	2,713	11,626	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of Series A preferred stock and warrants, net of issuance costs
-	-	24,671	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
0	0	-	-	-	-	-	-	-	-	72	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on finance lease liability
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on debt
-	-	-	-	-	-	-3,856	-4,744	-4,617	-4,493	-4,373	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on capital lease obligation
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	0	0	41,273	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from loans and advances from related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	341	106	0	0	0	-	-	-	-	10	0	0	0
Repayments to notes payable-related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Net cash provided by financing activities
27,277	25,290	39,161	38,501	34,856	33,414	40,807	0	0	0	-	-	-	-	-	-	-	-	-	-	331	96	91	107	72	43	27	0	97	107	0	0	0
Net increase in cash and cash equivalents
-2,376	-6,191	6,391	3,437	-929	-1,278	8,275	8,117	13,869	21,590	-12,959	-11,656	-37,573	1,624	-6,384	215	48,853	12,169	18,681	19,671	249	0	0	2	-9	-48	-59	-70	5	48	0	0	0
Supplemental Disclosure of Cash Flow Information:
Accrued dividends on Series A preferred stock
636	1,128	628	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants issued with long-term debt
440	440	210	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
1,258	1,154	878	579	317	95	157	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred offering costs in accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing costs included in accounts payable and accrued expenses
0	0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued statutory minimum withholding taxes on stock option exercises
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of Series A-1 preferred stock as dividends on Series A preferred stock
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred public offering costs in accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	0	0	921	-	0	0	0	-	-	-	-	-	-	-	1	0	0	0	0	0	0	0
Transfer from inventories to property and equipment in the field
183	340	425	740	946	883	812	0	0	0	-	-	-	-	587	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants issued with Series A preferred stock
-	-	4,162	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred offering costs in accounts payable and accrued expenses
-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0